Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network

Qian Gao1, Wenjun Zhang2, Tingting Li2

  • 1Affiliated Hospital of Shaoxing University of Endocrine and Metabolism Department, Zhejiang, China. 420293991@qq.com.

Scientific Reports
|January 8, 2022
PubMed

Insights

Patients with diabetes face higher COVID-19 risks. This study explores how Dipeptidyl peptidase-4 (DPP4), a coronavirus receptor, interacts with diabetes targets, suggesting DPP4 inhibitors and IL-6 antagonists may help manage severe cases.

Area of Science:

  • Biochemistry
  • Virology
  • Endocrinology

Background:

  • Diabetes mellitus patients exhibit increased susceptibility and mortality rates from Coronavirus disease 2019 (COVID-19).
  • Dipeptidyl peptidase-4 (DPP4) serves as a functional receptor for human coronaviruses, highlighting a potential link between diabetes and viral infection severity.

Purpose of the Study:

  • To investigate the intricate relationship between diabetes mellitus targets and DPP4.
  • To identify novel therapeutic strategies for managing patients with comorbid diabetes and COVID-19 through protein interaction network analysis.

Main Methods:

  • Collected diabetes mellitus targets from the GeneCards database, including DPP4.
  • Constructed and analyzed protein interaction networks using the String database.
  • Performed module identification, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.

Main Results:

  • Identified 43 DPP4-related proteins from diabetes targets, revealing three distinct functional modules.
  • Module 1 is associated with insulin secretion and the glucagon signaling pathway; Modules 2 and 3 are linked to signaling receptor binding.
  • LEP, apoB, INS, IL6, and ALB emerged as key proteins with high scores, indicating significant interactions within the network.

Conclusions:

  • Dipeptidyl peptidase-4 (DPP4) is extensively interconnected with critical proteins in diabetes mellitus.
  • COVID-19's impact on DPP4 in diabetic patients may contribute to elevated mortality.
  • DPP4 inhibitors and IL-6 antagonists represent potential therapeutic avenues to mitigate COVID-19's adverse effects in diabetic individuals.

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.0K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.7K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
280
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
77